retatrutide phase 2 diabetes weight loss 2024 New 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide Severe Obesity Trial Shows

The drug is quickly eliminated in the body without accumulation

plans restrict GLP-1 coverage outside of diabetes due to cost, often requiring step therapy or prior documented weight-loss attempts.

Week 1-4: 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12 (if needed): 1 mg once weekly, if further glycemic control is required Week 13 onwards (if needed): 2 mg once weekly, if your body can tolerate the previous dosage and further glycemic control is required This medication is started at 0.25 mg per week until you reach the maintenance dose

The stock is now up more than 30% since Eli Lilly reported first-quarter earnings on April 30

Questions like: Am I eating enough protein